Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00362050
Status:
COMPLETED
Last Update Posted:
2007-08-29
First Post:
2006-08-08
Brief Title:
RBx11160 Phase II Dose Ranging Study RBxMMV05-06
Sponsor:
Medicines for Malaria Venture
Organization:
Medicines for Malaria Venture
Organization Data
Organization:
Medicines for Malaria Venture
Class:
OTHER
Study ID:
RBxMMV05-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medicines for Malaria Venture
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Swiss Tropical Public Health Institute | OTHER |
| Ranbaxy Laboratories Limited | INDUSTRY |